Gabelli Funds LLC Galapagos Nv Transaction History

Gabelli Funds LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$42.27 - $57.6 $14,794 - $20,160	350 Added 4.19%	8,700 $452,000
Q2 2022 Aug 12, 2022	BUY	$52.3 - $71.59 $96,755 - $132,441	1,850 Added 28.46%	8,350 $466,000
Q4 2021 Feb 11, 2022	SELL	$47.03 - $57.12 $23,515 - $28,560	-500 Reduced 7.14%	6,500 $358,000
Q3 2021 Nov 12, 2021	BUY	$52.17 - $70.2 $26,085 - $35,100	500 Added 7.69%	7,000 $368,000
Q2 2021 Aug 13, 2021	BUY	$68.86 - $83.34 $68,860 - $83,340	1,000 Added 18.18%	6,500 $448,000
Q1 2021 May 14, 2021	BUY	$76.15 - $111.94 $418,825 - $615,670	5,500 New	5,500 $424,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.